AB
ACET icon

Amalgamated Bank’s Adicet Bio ACET Stock Holding History

Amalgamated Bank’s Portfolio ACET Stock Details ACET Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-62
Closed -$2K – 3003
2024
Q1 		$2K Sell
62
-111
-64% -$4.59K ﹤0.01% 2864
2023
Q4 		$5K Sell
173
-18
-9% -$392 ﹤0.01% 2935
2023
Q3 		$4K Hold
191
– – ﹤0.01% 2979
2023
Q2 		$7K Hold
191
– – ﹤0.01% 2979
2023
Q1 		$18K Sell
191
-50
-21% -$6.28K ﹤0.01% 2677
2022
Q4 		$34K Buy
241
+16
+7% +$3.99K ﹤0.01% 2585
2022
Q3 		$51K Hold
225
– – ﹤0.01% 2447
2022
Q2 		$53K Buy
225
+67
+42% +$14.7K ﹤0.01% 2444
2022
Q1 		$51K Buy
+158
New +$36.3K ﹤0.01% 2468

Other funds holding ACET

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CG
Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return
ACM
Aquilo Capital Management San Francisco, California $55.8M AUM 41.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return

Amalgamated Bank's ACET Position: Q2 2024 in Review

Amalgamated Bank sold out of Adicet Bio (ACET) in Q2 2024, closing a stake of 62 shares — an estimated $2K sold.

Amalgamated Bank first reported a position in ACET in Q1 2022 and held it in 9 quarters. The position peaked at $53K in Q2 2022. 86 funds tracked by Wall St. Rank hold ACET as of Q2 2024.

  • Amalgamated Bank reported no remaining Adicet Bio position as of Q2 2024 after selling out during the quarter.
  • Amalgamated Bank sold 62 Adicet Bio shares in Q2 2024, an estimated $2K.
  • Amalgamated Bank first reported a position in Adicet Bio in Q1 2022 and held it in 9 quarters.
  • Amalgamated Bank's Adicet Bio position peaked at $53K in Q2 2022.
  • 86 funds tracked by Wall St. Rank held Adicet Bio as of Q2 2024.

Based on Amalgamated Bank's 13F filing for Q2 2024, filed 12 Aug 2024.